Life Science Analytics (LSA)

Overview

Life Science Analytics is a biomedical data company that provides corporate intelligence and research products to life science companies and financial industry professionals. Business development officers, librarians and executives of biomedical companies, as well as vendors and consultants who serve those companies, turn to LSA for their corporate intelligence projects.

Our Products

Financial Reports
These reports contain the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market related data including relative strength, valuation and revenues.

Each report also includes earnings and earnings per share, margin and return ratios, financial strength, growth ratios, day’s sales outstanding, day’s outstanding inventory, cash and short-term investments per share and total common shares outstanding. Finally each report includes quarterly book value per share vs. share price. Much of the information contained in each report is included in both tabular and graphic formats.

Product Pipeline Reports
Each report contains: Business Summary; Contact Information; Selected Financial Data; Company Details; Product Glance (Table/Graph); Disease Hub Classification (Table/Graph); Product Pipeline; Product Catalog; Product Details with Description; Therapeutic Indication; Drug Class; Mechanism of Action; Current Trial; Trial Details; Partnering Details etc; Patent Details (if any); Recent Financings; Trademarks; Deals & Alliances; Management Profile; Recent Updates

Competitor Reports
These report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. Each report also includes recent company news updates

Deals & Alliances Reports
Each report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product, technology, miscellaneous), stage of development, list of partners, deal types (licensing, marketing, etc.), top deals by deal value, partners based on technology with detailed descriptions of the partner firm where disclosed, partners based on product with detailed descriptions of the partner firm where disclosed, partners in other non-product, non-technology deals, with detailed descriptions of the partner firm and terms when available. Each report also includes M&A statistics and recent partnering news updates by date.

Life Science Analytics (LSA)
 

List of reports from Life Science Analytics (LSA)

< prev 1  2  3  4  5  6  7  8  9  10  next >
Shalaks Pharmaceuticals Pvt. Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Systopic Laboratories Pvt. ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Columbia Laboratories Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
Ravenbhel Pharmaceuticals Pvt. Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Medarex Inc-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of ...  |  more...
$350.00
Mission Pharmacal Company-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
Ono Pharmaceutical Co., Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Cipla Medpro South Africa LTD. (formerly Enaleni Pharmaceuticals Ltd)-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline ...  |  more...
$350.00
DARA BioSciences, Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
KARNATAKA ANTIBIOTICS AND PHARMACEUTICALS LIMITED-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight ...  |  more...
$350.00
Hindustan Antibiotics Limited-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
H. Lundbeck A/S-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
XELR8 Holdings, Inc.-Therapeutic Competitors
1/7/2010 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  more...
$350.00
Kureha Corporation (formerly Kureha Chemical Industry Co., Ltd.)-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... stage of development, and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as ...  |  more...
$350.00
Shionogi, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
Shionogi & Co., Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Aastrom Biosciences Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
Alfresa Pharma Corporation-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
Advaxis Inc-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood ...  |  more...
$350.00
Chong Kun Dang Pharmaceutical Corp. (CKD Pharm)-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... of development, and competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well ...  |  more...
$350.00
Adonis Laboratories Pvt. Ltd.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... competitors by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into ...  |  more...
$350.00
Atria BPH, Inc.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
Almirall, S.A.-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
MIKA Pharma GmbH-Therapeutic Competitors Report
3/14/2011 | published by: Life Science Analytics (LSA)
... by therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the ...  |  more...
$350.00
ARCA biopharma, Inc.-Therapeutic Competitors
3/14/2011 | published by: Life Science Analytics (LSA)
... therapeutic indication. The report also includes recent company news updates. Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted ...  |  more...
$350.00
< prev 1  2  3  4  5  6  7  8  9  10  next >